Syros to Report Third Quarter 2024 Financial Results on Thursday, October 31, 2024
Syros Pharmaceuticals (NASDAQ:SYRS) has scheduled its third quarter 2024 financial results announcement and business update for Thursday, October 31, 2024, at 8:30 a.m. ET. The company will host a live conference call and webcast accessible via phone at (800) 549-8228 (domestic) or (289) 819-1520 (international) using conference ID 07454. A webcast replay will be available for approximately 30 days on the company's website.
Syros Pharmaceuticals (NASDAQ:SYRS) ha programmato l'annuncio dei suoi risultati finanziari del terzo trimestre 2024 e un aggiornamento aziendale per giovedì 31 ottobre 2024, alle 8:30 a.m. ET. L'azienda condurrà una conferenza telefonica in diretta e una trasmissione web accessibile tramite telefono al numero (800) 549-8228 (domestico) o (289) 819-1520 (internazionale) utilizzando l'ID conferenza 07454. Una registrazione della trasmissione sarà disponibile per circa 30 giorni sul sito web dell'azienda.
Syros Pharmaceuticals (NASDAQ:SYRS) ha programado el anuncio de sus resultados financieros del tercer trimestre de 2024 y una actualización de negocios para el jueves 31 de octubre de 2024, a las 8:30 a.m. ET. La empresa llevará a cabo una conferencia telefónica en vivo y una transmisión por Internet accesible por teléfono al (800) 549-8228 (nacional) o al (289) 819-1520 (internacional) utilizando el ID de conferencia 07454. Una repetición de la transmisión estará disponible durante aproximadamente 30 días en el sitio web de la empresa.
Syros Pharmaceuticals (NASDAQ:SYRS)는 2024년 3분기 재무 결과 발표 및 사업 업데이트를 2024년 10월 31일 목요일 오전 8시 30분(동부 표준시)에 예정하고 있습니다. 회사는 전화로 접속할 수 있는 라이브 컨퍼런스 콜과 웹캐스트를 진행하며, 전화번호는 (800) 549-8228 (국내) 또는 (289) 819-1520 (국제)입니다. 회의 ID는 07454입니다. 웹캐스트 재생은 회사 웹사이트에서 약 30일 동안 이용 가능합니다.
Syros Pharmaceuticals (NASDAQ:SYRS) a programmé l'annonce de ses résultats financiers du troisième trimestre 2024 et une mise à jour de l'entreprise pour le jeudi 31 octobre 2024, à 8h30 ET. L'entreprise organisera une conférence téléphonique en direct et un webinaire accessibles par téléphone au (800) 549-8228 (national) ou au (289) 819-1520 (international) en utilisant l'identifiant de conférence 07454. Un replay du webinaire sera disponible pendant environ 30 jours sur le site web de l'entreprise.
Syros Pharmaceuticals (NASDAQ:SYRS) hat die Bekanntgabe seiner Finanzergebnisse für das dritte Quartal 2024 und ein Geschäftsupdate auf Donnerstag, den 31. Oktober 2024, um 8:30 Uhr ET angesetzt. Das Unternehmen wird eine Live-Konferenzschaltung und ein Webcast anbieten, die telefonisch unter (800) 549-8228 (inland) oder (289) 819-1520 (international) mit der Konferenz-ID 07454 zugänglich sind. Eine Aufzeichnung des Webcasts wird etwa 30 Tage lang auf der Website des Unternehmens verfügbar sein.
- None.
- None.
To access the live conference call, please dial (800) 549-8228 (domestic) or (289) 819-1520 (international) and refer to conference ID 07454. A webcast of the call will also be available on the Investors & Media section of the Syros website at www.syros.com. An archived replay of the webcast will be available for approximately 30 days following the call.
About Syros Pharmaceuticals
Syros is committed to developing new standards of care for the frontline treatment of patients with hematologic malignancies. Driven by the motivation to help patients with blood disorders that have largely eluded other targeted approaches, Syros is developing tamibarotene, an oral selective RARα agonist in frontline patients with higher-risk myelodysplastic syndrome with RARA gene overexpression. For more information, visit www.syros.com and follow us on Twitter (@SyrosPharma) and LinkedIn.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241024190576/en/
Syros
Karen Hunady
Director of Corporate Communications & Investor Relations
1-857-327-7321
khunady@syros.com
Investors
Amanda Isacoff
Precision AQ
212-362-1200
amanda.isacoff@precisionaq.com
Source: Syros Pharmaceuticals
FAQ
When will Syros Pharmaceuticals (SYRS) report Q3 2024 earnings?
How can investors access Syros Pharmaceuticals (SYRS) Q3 2024 earnings call?
How long will Syros Pharmaceuticals (SYRS) Q3 2024 earnings webcast be available?
